首页> 外国专利> The use of kauranes compounds in the manufacture of medicament for treatment of cardiac hypertropy and pulmonary hypertension

The use of kauranes compounds in the manufacture of medicament for treatment of cardiac hypertropy and pulmonary hypertension

机译:贝壳杉酸酯类化合物在制造用于治疗心肌肥大和肺动脉高压的药物中的用途

摘要

The invention relates novel pharmaceutical use of kaurane compounds of formula (I) in treating and preventing cardiac hypertrophy and myocardium remodeling. The said compounds also can significantly ameliorate pulmonary hypertension and preventing vascular hypertrophy. The said compounds can also be used to suppress fibrosis and to treat erection dysfunction, neurological degenerations and other related diseases by modulating cGMP or cAMP signal pathway and/or by reducing reactive oxygen species (ROS). Wherein R
机译:本发明涉及式(I)的月桂烷化合物在治疗和预防心脏肥大和心肌重塑中的新的药物用途。所述化合物还可以显着改善肺动脉高压并预防血管肥大。所述化合物还可通过调节cGMP或cAMP信号途径和/或通过减少活性氧(ROS)而用于抑制纤维化并治疗勃起功能障碍,神经变性和其他相关疾病。其中R

著录项

  • 公开/公告号AU2016318815A1

    专利类型

  • 公开/公告日2018-04-26

    原文格式PDF

  • 申请/专利权人 KEY-PHARMA BIOMEDICAL INC.;WEN TAN;

    申请/专利号AU20160318815

  • 发明设计人 TAN WEN;

    申请日2016-09-07

  • 分类号A61K31/045;A61K31/19;A61P3;A61P9;A61P15/10;A61P25;

  • 国家 AU

  • 入库时间 2022-08-21 12:45:32

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号